Viusid

Asset

Stage
Phase 3, no development reported
Modality
Supplement
Target
Not known
3
Indications
38
Trials
1
Developer

No development reported since July 2009. Last activity: Trial NCT00502086 completed. clinicaltrials.gov

Indications

3

In the full profile

  • Target and mechanism1
  • Owner and partners1
  • Trials38
  • Evidence for its targets1
  • Competitors12
  • Signals7

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets